Medications & Pregnancy Safety

Pregnancy drug safety centers on teratogenic risk, which varies by trimester and mechanism. The first trimester (organogenesis, weeks 3–8) carries the highest risk for structural defects. Key absolute contraindications include isotretinoin (category X — causes craniofacial, cardiac, and CNS defects even with a single dose; requires enrollment in the iPLEDGE program), warfarin (crosses the placenta; causes nasal hypoplasia and stippled epiphyses — switch to heparin, which does NOT cross the placenta), ACE inhibitors and ARBs (renal agenesis, oligohydramnios, especially in second and third trimesters), methotrexate (folate antagonist, potent abortifacient), valproic acid (neural tube defects), and tetracyclines (permanent tooth discoloration and impaired bone growth after week 16). Statins, misoprostol, and live vaccines are also contraindicated. Safe alternatives the nurse should recognize: acetaminophen over NSAIDs (NSAIDs after 20 weeks risk premature ductus arteriosus closure and oligohydramnios), penicillins and cephalosporins for infections, labetalol or methyldopa for chronic hypertension, and insulin as the preferred agent for gestational diabetes (metformin is used in practice but insulin remains first-line per ACOG). The nurse's role is to verify pregnancy status before administering any high-risk medication and to teach the client never to start, stop, or change medications without provider guidance.